AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies

Go back to AnaptysBio Announces Portfolio Update Across Best-in-Class Immune Cell Modulating Antibodies
(NASDAQ: ANAB) Delayed: 53.82 -1.09 (1.99%)
Previous Close $54.91    52 Week High
Open $55.16    52 Week Low
Day High $55.16    P/E N/A 
Day Low $53.26    EPS
Volume 144,554